ketamine pulmonary hypertension

Ketamine has been associated with the potential development of pulmonary arterial hypertension (PAH), a serious adverse effect. PAH is characterized by elevated blood pressure in the pulmonary arteries, which can increase the strain on the heart and potentially result in heart failure.

Initially, mild PAH may present without noticeable symptoms. However, as the condition advances, patients might exhibit symptoms such as shortness of breath, fatigue, and chest pain. In extreme cases, PAH can lead to right ventricular hypertrophy and heart failure, posing a significant risk to life. Furthermore, PAH induced by ketamine could be influenced by various factors, including the patient’s age, health status, frequency, and dosage of ketamine use. Prolonged or excessive ketamine use may also heighten the risk of PAH.

Consequently, if you are using ketamine and notice any symptoms indicative of PAH, it is imperative to seek medical attention promptly. Additionally, adhere to your physician’s instructions regarding medication use, refraining from self-adjusting the dosage or altering the treatment plan. Engage in regular health check-ups and blood pressure monitoring to identify and manage any potential issues promptly.